These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24026291)

  • 21. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
    Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of apoptosis of endothelial cells by Viscum album: a role for anti-tumoral properties of mistletoe lectins.
    Duong Van Huyen JP; Bayry J; Delignat S; Gaston AT; Michel O; Bruneval P; Kazatchkine MD; Nicoletti A; Kaveri SV
    Mol Med; 2002 Oct; 8(10):600-6. PubMed ID: 12477970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.
    Ostermann T; Raak C; Büssing A
    BMC Cancer; 2009 Dec; 9():451. PubMed ID: 20021637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
    Kelter G; Schierholz JM; Fischer IU; Fiebig HH
    Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study.
    Bar-Sela G; Wollner M; Hammer L; Agbarya A; Dudnik E; Haim N
    Eur J Cancer; 2013 Mar; 49(5):1058-64. PubMed ID: 23218588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
    Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
    BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide involvement in the anti-tumor effect of mistletoe (Viscum album L.) extracts Iscador on human macrophages.
    Mossalayi MD; Alkharrat A; Malvy D
    Arzneimittelforschung; 2006 Jun; 56(6A):457-60. PubMed ID: 16927526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extract from mistletoe, Viscum album L., reduces Hsp27 and 14-3-3 protein expression and induces apoptosis in C6 rat glioma cells.
    Uçar EÖ; Arda N; Aitken A
    Genet Mol Res; 2012 Aug; 11(3):2801-13. PubMed ID: 23007975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador).
    Gorter RW; van Wely M; Stoss M; Wollina U
    Am J Ther; 1998 May; 5(3):181-7. PubMed ID: 10099057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a preparation from Viscum album on tumor development in vitro and in mice.
    Kuttan G; Vasudevan DM; Kuttan R
    J Ethnopharmacol; 1990 Apr; 29(1):35-41. PubMed ID: 2345458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
    Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
    Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viscumins functionally modulate cell motility-associated gene expression.
    Schötterl S; Hübner M; Armento A; Veninga V; Wirsik NM; Bernatz S; Lentzen H; Mittelbronn M; Naumann U
    Int J Oncol; 2017 Feb; 50(2):684-696. PubMed ID: 28101577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin.
    Wang MB; Yip HT; Srivatsan ES
    Laryngoscope; 2001 Jun; 111(6):982-8. PubMed ID: 11404608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
    Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
    Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.